Overall, the incidence of latent MMP-9 and activated MMP-9 forms was similar in stable and exacerbated COPD (43.4 % in stable vs 42.9 % in exacerbated, p-value = 0.958). Here, MMP9 is linked to chronic obstructive pulmonary disease.